Accuray Incorporated (0H8I.L)
USD 1.54
(-1.0%)
USD 1.54
(-1.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 164.4 Million USD | -4.17% |
| 2022 | 171.56 Million USD | -0.2% |
| 2021 | 171.9 Million USD | 1.12% |
| 2020 | 170 Million USD | -10.2% |
| 2019 | 189.3 Million USD | 18.43% |
| 2018 | 159.84 Million USD | 21.95% |
| 2017 | 131.07 Million USD | 154.28% |
| 2016 | 51.54 Million USD | -69.77% |
| 2015 | 170.51 Million USD | -14.6% |
| 2014 | 199.65 Million USD | 2.07% |
| 2013 | 195.61 Million USD | -1.59% |
| 2012 | 198.76 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 FY | 164.4 Million USD | -4.17% |
| 2023 Q1 | 169.79 Million USD | -1.03% |
| 2023 Q2 | 168.02 Million USD | -1.04% |
| 2023 Q3 | 166.24 Million USD | -1.06% |
| 2023 Q4 | 164.4 Million USD | -1.11% |
| 2022 Q3 | 172.83 Million USD | -0.73% |
| 2022 Q4 | 171.56 Million USD | -0.73% |
| 2022 Q1 | 170.62 Million USD | -0.75% |
| 2022 Q2 | 174.1 Million USD | 2.04% |
| 2022 FY | 171.56 Million USD | -0.2% |
| 2021 Q3 | 173.19 Million USD | -0.74% |
| 2021 FY | 171.9 Million USD | 1.12% |
| 2021 Q1 | 194.14 Million USD | 14.2% |
| 2021 Q2 | 174.49 Million USD | -10.12% |
| 2021 Q4 | 171.9 Million USD | -0.74% |
| 2020 Q4 | 170 Million USD | -7.09% |
| 2020 Q2 | 189.04 Million USD | -3.6% |
| 2020 Q1 | 196.11 Million USD | -8.13% |
| 2020 Q3 | 182.97 Million USD | -3.21% |
| 2020 FY | 170 Million USD | -10.2% |
| 2019 Q2 | 211.03 Million USD | -1.39% |
| 2019 FY | 189.3 Million USD | 18.43% |
| 2019 Q4 | 213.48 Million USD | -1.41% |
| 2019 Q3 | 216.54 Million USD | 2.61% |
| 2019 Q1 | 214 Million USD | 33.89% |
| 2018 Q2 | 136.82 Million USD | 6.13% |
| 2018 Q1 | 128.92 Million USD | -1.64% |
| 2018 FY | 159.84 Million USD | 21.95% |
| 2018 Q4 | 159.84 Million USD | 9.51% |
| 2018 Q3 | 145.95 Million USD | 6.68% |
| 2017 Q1 | 118.86 Million USD | 130.6% |
| 2017 Q4 | 131.07 Million USD | -2.42% |
| 2017 FY | 131.07 Million USD | 154.28% |
| 2017 Q3 | 134.32 Million USD | 2.99% |
| 2017 Q2 | 130.42 Million USD | 9.72% |
| 2016 Q1 | 171.52 Million USD | 0.59% |
| 2016 Q4 | 51.54 Million USD | -5.13% |
| 2016 FY | 51.54 Million USD | -69.77% |
| 2016 Q3 | 54.33 Million USD | -67.4% |
| 2016 Q2 | 166.66 Million USD | -2.83% |
| 2015 FY | 170.51 Million USD | -14.6% |
| 2015 Q4 | 170.51 Million USD | 0.07% |
| 2015 Q3 | 170.39 Million USD | 54.66% |
| 2015 Q2 | 110.17 Million USD | 0.49% |
| 2015 Q1 | 109.63 Million USD | -45.09% |
| 2014 Q1 | 197.37 Million USD | 0.9% |
| 2014 Q2 | 199.15 Million USD | 0.9% |
| 2014 Q4 | 199.65 Million USD | -0.66% |
| 2014 Q3 | 200.98 Million USD | 0.92% |
| 2014 FY | 199.65 Million USD | 2.07% |
| 2013 Q2 | 201.08 Million USD | 0.58% |
| 2013 Q3 | 202.28 Million USD | 0.6% |
| 2013 Q4 | 195.61 Million USD | -3.3% |
| 2013 FY | 195.61 Million USD | -1.59% |
| 2013 Q1 | 199.91 Million USD | 0.58% |
| 2012 Q4 | 198.76 Million USD | 0.56% |
| 2012 FY | 198.76 Million USD | 0.0% |
| 2012 Q2 | 81.56 Million USD | 0.0% |
| 2012 Q3 | 197.65 Million USD | 142.33% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -7923.426% |
| Align Technology, Inc. | 96.96 Million USD | -69.54% |
| Elevance Health Inc. | 23.24 Billion USD | 99.293% |
| AxoGen, Inc. | 46.6 Million USD | -252.767% |
| Boston Scientific Corporation | 8.56 Billion USD | 98.081% |
| CVS Health Corporation | 74.67 Billion USD | 99.78% |
| Cardinal Health, Inc. | 4.58 Billion USD | 96.413% |
| Centene Corporation | 17.69 Billion USD | 99.071% |
| DaVita Inc. | 8.05 Billion USD | 97.958% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 99.551% |
| Hologic, Inc. | 2.49 Billion USD | 93.416% |
| Humana Inc. | 10.21 Billion USD | 98.39% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 73.607% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 95.945% |
| Masimo Corporation | 871.7 Million USD | 81.14% |
| McKesson Corporation | 5.45 Billion USD | 96.984% |
| Patterson Companies, Inc. | 328.91 Million USD | 50.017% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 96.272% |
| ResMed Inc. | 697.31 Million USD | 76.424% |
| Henry Schein, Inc. | 1.93 Billion USD | 91.495% |
| Teladoc Health, Inc. | 1.58 Billion USD | 89.605% |
| Universal Health Services, Inc. | 4.71 Billion USD | 96.514% |
| Veeva Systems Inc. | 46.44 Million USD | -253.998% |
| Baxter International Inc. | 11.06 Billion USD | 98.514% |
| Becton, Dickinson and Company | 14.73 Billion USD | 98.885% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 300.244% |
| Danaher Corporation | 17.66 Billion USD | 99.069% |
| Stryker Corporation | 10.9 Billion USD | 98.492% |
| Medtronic plc | 23.87 Billion USD | 99.311% |